PT - JOURNAL ARTICLE AU - Wu, Lianpin AU - Jin, Qike AU - Chen, Jie AU - He, Jiawei AU - Dong, Jianghu (James) TI - Chest CT Scan of Hospitalized Patients with COVID-19: A Case-Control Study AID - 10.1101/2020.04.07.20056762 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.07.20056762 4099 - http://medrxiv.org/content/early/2020/04/11/2020.04.07.20056762.short 4100 - http://medrxiv.org/content/early/2020/04/11/2020.04.07.20056762.full AB - Introduction This paper sought to investigate the clinical characteristic differences between suspected and confirmed patients with COVID-19 from CT scan to prevent and treat this infectious disease, since the coronavirus outbreak in the world has seriously affected the quality of life.Methods We proposed to use a retrospective case-control study to give a comparison between suspected patients and confirmed patients in the clinical characteristics.Results (56%) patients were confirmed for COVID-19 from suspected 167 patients. We find that elder people were more likely to be infected by COVID-19. Among the confirmed 94 patients, 2 (2%) patients were admitted to an intensive care unit, and 0 (0%) patients died during the study period. We find that images of CT scan of patients with a COVID-19 are significantly different from patients without a COVID-19.Conclusions To our best knowledge, it is the first time to use the case-control design to study the coronavirus disease, since it is particularly appropriate for investigating infectious disease outbreaks. The clinical treatment experience in this study can supply a guideline for treating COVID-19 as the number of the infected patients is increasing in the world. Compared with other studies, we find that the mortality rate and the intensive care unit rate can be reduced if patients can be treated timely in the right identification and detection with nucleic acid testing and chest CT scan. Therefore, we recommend nucleic acid testing and chest CT scan for the clinical treatment practice from this successful clinical treatment study.Competing Interest StatementThe authors have declared no competing interest.Funding StatementnoAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesHomepage: www.unmc.edu/publichealth/departments/biostatistics/jianghu-dong.html